|

Recovery From ICUAW Following Severe Respiratory and Cardiac Failure

RECRUITINGSponsored by Barts & The London NHS Trust
Actively Recruiting
SponsorBarts & The London NHS Trust
Started2019-04-09
Est. completion2026-09-26
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT03753412

Summary

To observe and identify determinants of recovery from intensive care unit-acquired weakness (ICUAW) following a severe cardiorespiratory failure requiring extra-corporeal membrane oxygenation (ECMO). Additionally, to discover the effects of ICUAW on physical function and health-related quality of life (HRQoL) after critical illness. CLEVERER is a clinical observational pilot study.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Above the age of 18
* Adults with severe cardio-respiratory failure requiring ECMO.
* Adults who have had personal and professional consultees agree to enrol them in the trial.

Exclusion criteria:

* Previous Stroke
* Neuromuscular disease
* Malignancy
* Underlying neuromuscular disease
* paediatrics

Conditions8

Acute Respiratory Distress SyndromeCardiac FailureCritical Illness MyopathyHeart DiseaseIntensive Care (ICU) MyopathyIntensive Care NeuropathyIntensive Care Unit SyndromeRespiratory Failure

Browse More Trials

Heart Disease trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.